<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04524312</url>
  </required_header>
  <id_info>
    <org_study_id>WarsawMU/kmod</org_study_id>
    <nct_id>NCT04524312</nct_id>
  </id_info>
  <brief_title>Dynamic Congruence Total Knee Replacement vs Posterior-stabilized</brief_title>
  <acronym>K-Mod</acronym>
  <official_title>Does Dynamic Congruence Design Improve Gait After Total Knee Replacement in Comparison to Posterior-stabilized One? - Prospective Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of Warsaw</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical University of Warsaw</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study compares and evaluates differences in movement analysis, patient-reported outcome&#xD;
      between patients undergoing total knee arthroplasty with use of either Zimmer Biomet NexGen&#xD;
      with posterior stabilization and Bioimplanti K-Mod cruciate-retaining with dynamic congruence&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The aim of this study is to assess and compare kinematic and time-space gait parameters in&#xD;
      patients after total knee arthroplasty, who will undergo the surgery with the use of either&#xD;
      posterior-stabilized (PS) or dynamic congruence (DC) implants.&#xD;
&#xD;
      Materials and methods To this study 56 consecutive patients undergoing total knee&#xD;
      arthroplasty will be recruited. Study protocol is designed as a prospective, blinded,&#xD;
      parallel-group, superiority trial, with balanced randomization [1:1]. All participants will&#xD;
      be operated in single clinical orthopedic department, by single high-volume surgeon, who&#xD;
      performed more than 3000 total knee arthroplasties in his professional career.&#xD;
&#xD;
      Before the surgery patients will fulfill the author's questionnaire concerning their age,&#xD;
      height and body mass, level of activity and VAS (Visual Analogue Scale).&#xD;
&#xD;
      After the surgery 1 to 3 years postoperatively three-dimensional gait analysis will performed&#xD;
      with use of BTS SMART device. This device uses passive markers technology and registers the&#xD;
      movement by six cameras. To perform full gait analysis several data concerning patients&#xD;
      anthropometry will be collected (lower limb length, knee and ankle joint width, width and&#xD;
      depth of the pelvis). Whole gait analysis will be performed by experienced single clinical&#xD;
      biomechanist accordingly to the Davis protocol. Markers will be installed on the patients'&#xD;
      limbs on the following points: base of sacral bone, greater trochanter of the femur, lateral&#xD;
      femoral condyle, head of the fibula, lateral malleoli, head of the V metatarsal bone).&#xD;
&#xD;
      Participants will walk barefoot for 10 meters quadruple times. Following time-space and&#xD;
      kinematic parameters will be assessed:&#xD;
&#xD;
      Time-space parameters Single stance time (T1) [%] Swing time (T2) [%] Double-stance time (T3)&#xD;
      [%] Step length (SL) [m] Mean gait velocity (Vm) [m/s] Cadence (C) [number of steps/min]&#xD;
&#xD;
      Kinematic parameters:&#xD;
&#xD;
      Operated knee range of flexion during swing phase [°]&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">December 1, 2017</start_date>
  <completion_date type="Actual">September 26, 2020</completion_date>
  <primary_completion_date type="Actual">September 26, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
    <masking_description>Participant will not be informed which type of prosthesis was used in their particular case.&#xD;
Outcomes Assessor will not be informed which type of prosthesis was used in particular patient.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Time of swing phase</measure>
    <time_frame>Time Frame: 1-3 years after surgery</time_frame>
    <description>Change from baseline part of swing phase time during gait, measured in percentage&#xD;
Change from baseline part of swing phase time during gait, measured in percentage</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Time of stance phase</measure>
    <time_frame>Time Frame: 1-3 years after surgery</time_frame>
    <description>Change from baseline part of stance phase time during gait, measured in percentage</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Time of double-stance phase</measure>
    <time_frame>Time Frame: 1-3 years after surgery</time_frame>
    <description>Change from baseline part of double-stance phase time during gait, measured in percentage</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Stride length</measure>
    <time_frame>Time Frame: 1-3 years after surgery</time_frame>
    <description>Change from baseline length of stride during gait, measured in meters</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Cadence</measure>
    <time_frame>Time Frame: 1-3 years after surgery</time_frame>
    <description>Change from baseline number of strides per minute of walking</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Mean gait velocity</measure>
    <time_frame>Time Frame: 1-3 years after surgery</time_frame>
    <description>Change from baseline mean values of gait speed, measured in meters per second</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Range of maximal hip extension for both limbs during ending part of mid-stance phase</measure>
    <time_frame>Time Frame: 1-3 years after surgery</time_frame>
    <description>Change from baseline range of maximal hip extension for both limbs during ending part of mid-stance phase, measured in degrees</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Range of pelvic drop in frontal plane on the opposite site of the bearing limb</measure>
    <time_frame>Time Frame: 1-3 years after surgery</time_frame>
    <description>Change from baseline range of pelvic drop in frontal plane on the opposite site of the bearing limb, measured in degrees</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">56</enrollment>
  <condition>Osteo Arthritis Knee</condition>
  <condition>Surgery</condition>
  <condition>Joint Diseases</condition>
  <arm_group>
    <arm_group_label>NexGen</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients undergoing total knee replacement for treatment of primary knee ostearthritis with use of Zimmer Biomet NexGen prosthesis</description>
  </arm_group>
  <arm_group>
    <arm_group_label>K-Mod</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients undergoing total knee replacement for treatment of primary knee ostearthritis with use of Bioimplanti K-MOD prosthesis</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Total knee replacement</intervention_name>
    <description>Participant will undergo total knee replacement performed via anterior parapatellar approach with either Posterior-stabilized or retaining cruciate-retaining with dynamic congruence implant</description>
    <arm_group_label>K-Mod</arm_group_label>
    <arm_group_label>NexGen</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Biomechanics</intervention_name>
    <description>Participants will be asked to perform biomechanical assesment before and following surgery at baseline, 6-8 weeks and 6-months postoperatively</description>
    <arm_group_label>K-Mod</arm_group_label>
    <arm_group_label>NexGen</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>NexGen Ps or Bioimplanti K-MOD implant</intervention_name>
    <description>Participant are randomly allocated to receive one of the NexGen PS or Biomplanti K-MOD total knee implant for treatment of end-stage knee osteoarthritis.</description>
    <arm_group_label>K-Mod</arm_group_label>
    <arm_group_label>NexGen</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  agreement to participate in the study&#xD;
&#xD;
          -  BMI (kg/m2) less than 40&#xD;
&#xD;
          -  ability to walk for 10 meters&#xD;
&#xD;
          -  knee flexion more or equal of 90 degrees&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  unwillingness to participate in the study&#xD;
&#xD;
          -  osteoarthritis due to the rheumatological disease&#xD;
&#xD;
          -  disorders associated with nerve-muscle signal transmission&#xD;
&#xD;
          -  neurological disorders associated with dizziness, nystagmus or other conditions that&#xD;
             might influence balance during activity&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bartosz M. Maciąg, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medical University of Warsaw</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Othopedics and Rehabilitation, Medical University of Warsaw</name>
      <address>
        <city>Warszawa</city>
        <state>Mazowieckie</state>
        <zip>03-984</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Poland</country>
  </location_countries>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>August 19, 2020</study_first_submitted>
  <study_first_submitted_qc>August 19, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">August 24, 2020</study_first_posted>
  <last_update_submitted>September 26, 2020</last_update_submitted>
  <last_update_submitted_qc>September 26, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">September 29, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Medical University of Warsaw</investigator_affiliation>
    <investigator_full_name>Artur Stolarczyk</investigator_full_name>
    <investigator_title>MD, PhD</investigator_title>
  </responsible_party>
  <keyword>osteoarthritis</keyword>
  <keyword>knee</keyword>
  <keyword>congruence</keyword>
  <keyword>posterior-stabilized</keyword>
  <keyword>cruciate-retaining</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Joint Diseases</mesh_term>
    <mesh_term>Osteoarthritis</mesh_term>
    <mesh_term>Osteoarthritis, Knee</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

